| Total Revenue | | 0 | 0 | 0 | |
| Cost of Goods Sold Incl. D&A | | 0 | 0 | 6 |
| Gross Profit | | 0 | 0 | -6 |
| Selling, General and Administrative Excl. Other | | 235 | 152 | 168 |
| Research and Development | | 494 | 358 | 271 |
| Other Operating Expense | | 0 | 0 | 0 |
| Operating Income | | -729 | -510 | -445 |
| Interest Expense | | 0 | 0 | 16 |
| Unusual Expense | | — | — | — |
| Non-Operating Income (Expense) | | -111 | 27 | 13 |
| Net Income Before Taxes | | -618 | -537 | -457 |
| Income Taxes | | 0 | 0 | 1 |
| Consolidated Net Income | | -618 | -537 | -458 |
| Net Income From Continuing Operations | | -618 | -537 | -458 |
| Net Income | | -618 | -537 | -458 |
| EPS (Recurring) | | -0.99 | -1.42 | -1.69 |
| EPS (Basic, Before Extraordinaries) | | -0.99 | -1.42 | -1.69 |
| EPS (Diluted) | | -0.99 | -1.42 | -1.69 |
| EBITDA | | -597 | -525 | -452 |
| Other After Tax Adjustments | | — | — | — |
| Stock Option Compensation Expense | | — | — | — |
| Price To Earnings Ratio | | — | — | — |
| Price To Sales Ratio | | — | — | — |
| Gross Margin | | — | — | — |
| Operating Margin | | — | — | — |
| Net Margin | | — | — | — |
| Shares Outstanding | | 624 | 377 | 270 |
| Market Capitalization | | 4,692 | — | — |
| Operating Lease Expense | | — | — | — |
